Tramadol and Dermatitis exfoliative generalised - a phase IV clinical study of FDA data
Summary:
Dermatitis exfoliative generalised is reported as a side effect among people who take Tramadol (tramadol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Paracetamol, and have Osteitis.
The phase IV clinical study analyzes which people have Dermatitis exfoliative generalised when taking Tramadol. It is created by eHealthMe based on reports of 229,782 people who have side effects when taking Tramadol from the FDA, and is updated regularly.
What is Tramadol?
Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,800 Tramadol users. Check the latest studies of Tramadol.
What is Dermatitis exfoliative generalised?
Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface) is found to be associated with 260 drugs and 198 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative generalised.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
229,782 people reported to have side effects when taking Tramadol.
Among them, 28 people (0.01%) have Dermatitis exfoliative generalised.

Among these 28 people:
How long have people been on Tramadol when they have Dermatitis exfoliative generalised? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Dermatitis exfoliative generalised when taking Tramadol? *
- female: 73.08 %
- male: 26.92 %
What is the age of people who have Dermatitis exfoliative generalised when taking Tramadol? *
- 0-1: 0.0 %
- 2-9: 3.85 %
- 10-19: 26.92 %
- 20-29: 0.0 %
- 30-39: 11.54 %
- 40-49: 7.69 %
- 50-59: 7.69 %
- 60+: 42.31 %
What are other drugs people take besides Tramadol? *
- Paracetamol: 9 people, 32.14%
- Tarka: 7 people, 25.00%
- Acetaminophen: 4 people, 14.29%
- Vancomycin: 4 people, 14.29%
- Bisoprolol Fumarate: 3 people, 10.71%
- Levothyroxine Sodium: 3 people, 10.71%
- Enoxaparin Sodium: 3 people, 10.71%
- Nexium: 3 people, 10.71%
- Clindamycin Hydrochloride: 3 people, 10.71%
- Potassium Chloride: 3 people, 10.71%
What are other side effects people have besides Dermatitis exfoliative generalised? *
- Hypotension (abnormally low blood pressure): 11 people, 39.29%
- Acute Kidney Failure: 7 people, 25.00%
- Bradycardia (abnormally slow heart action): 7 people, 25.00%
- Hepatocellular Injury (liver injury): 7 people, 25.00%
- Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 7 people, 25.00%
- Coughing Up Blood: 7 people, 25.00%
- Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light): 7 people, 25.00%
- Bradypnea: 7 people, 25.00%
- Drowsiness: 7 people, 25.00%
- Fever: 5 people, 17.86%
What are the existing conditions these people have? *
- Poisoning Deliberate: 4 people, 14.29%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 14.29%
- Osteitis (a general term for inflammation of bone): 4 people, 14.29%
- Mediastinitis (inflammation of the tissues in the mid-chest): 3 people, 10.71%
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 7.14%
- Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 2 people, 7.14%
- High Blood Pressure: 1 person, 3.57%
- Arrhythmias (irregular heartbeat): 1 person, 3.57%
- Blood Calcium Decreased: 1 person, 3.57%
- Cardiac Failure Congestive: 1 person, 3.57%
* Approximation only. Some reports may have incomplete information.
Do you take Tramadol and have Dermatitis exfoliative generalised?
- Check whether Dermatitis exfoliative generalised is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tramadol:
- Tramadol (235,800 reports)
Dermatitis exfoliative generalised treatments and more:
- Dermatitis exfoliative generalised (3,193 reports)
How severe was Dermatitis exfoliative generalised and when was it recovered:
Expand to all the drugs that have ingredients of tramadol hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tramadol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Dermatitis exfoliative generalised:
- Dermatitis exfoliative generalised (260 drugs)
Browse all the conditions that are associated with Dermatitis exfoliative generalised:
- Dermatitis exfoliative generalised (198 conditions)
Related publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Tramadol) and Tramadol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Topiramate cause Pulmonary Congestion? - 5 seconds ago
- Neutrophil Count Increased and drugs of ingredients of atorvastatin calcium - 6 seconds ago
- Could Topiramate cause Joint Warmth? - 10 seconds ago
- Could Nabumetone cause Aphonia? - 16 seconds ago
- Could Nexium cause Appendicitis? - 24 seconds ago
- Could Amlodipine cause The Flu? - 26 seconds ago
- Hyperphosphataemia and Gastric Ulcer - 28 seconds ago
- Hyperlipidaemia and Breast Cancer - 32 seconds ago
- Hot Flush and Insomnia - 38 seconds ago
- Hodgkin'S Lymphoma and Abdominal Pain - 45 seconds ago